For how we live.
Among privately insured patients, 63% with IVF coverage had a baby within 2.5 years versus 53% without. The gap was driven mostly by covered patients starting more cycles — not a higher success rate per cycle.
A tri-agency final rule, effective 7 December, overhauls the machine-readable price files insurers must post and requires cost estimates by phone. The changes apply to plan years from 1 January 2027.
A meta-analysis of 15 cohorts found 45% of deaths in people with intellectual and developmental disabilities were classed as avoidable — about 3.6 times the rate in people without disabilities, on rich-country data.
RESOLVE randomised 880 treatment-naive, non-cirrhotic patients to a shorter sofosbuvir–velpatasvir course; cure rates were non-inferior to the 12-week standard, with implications for the cost of elimination programmes.
The final FY2027 rule lifts the federal per diem base rate to $912.40 and the electroconvulsive-therapy rate to $688.59 from 1 October, adds a standardised patient-assessment tool, and drops two quality measures.
A mandatory CMS payment model finalised 2 October recalculates inflation rebates for certain physician-administered drugs against an international benchmark, and can cut a patient's coinsurance to 10%.
In the TB-Speed project, trained nurses produced valid Xpert Ultra results in 99.6% to 100% of child samples and returned hospital results within three hours far more often than laboratories.
A trial across 24 Zambian clinics found a person-centred care package lifted the share of patients in care a year after a treatment gap from 51.5% to 60.1%, and halved repeat interruptions.
In the RESPOND randomised trial, guided self-help and remote problem-solving delivered by non-professionals cut anxiety and depression scores well below usual care at follow-up.
A run of CDC sole-source awards in August 2026 sends millions directly to the health ministries of Ethiopia, Zambia and Ukraine — a bet on host-government ownership of the HIV response by 2030.
External validation of the PAANTHER decision algorithm in 277 children across four African countries recorded 93.3% negative predictive value and 97.4% sensitivity against a composite reference standard.
Fighting after the 2021 coup concentrated where hospital access was already worst. The population living with both poor access and intense conflict rose from 0.4 to 3.1 million in three years.
A survey of 1,042 people in the Syrian city found high prices the leading barrier, and more than half said they knew of deaths they attributed to medication shortages.
An autonomous AI for diabetic retinopathy hit 87.2% sensitivity in primary care. A smartphone acuity test agreed with a reference chart to within 0.07 logMAR. Both are triage, not diagnosis.
A WHO data-set analysis shows how mobile and hospital teams split the load of hypertension, diabetes and epilepsy care during the war, while a separate study tracked dialysis capacity falling.
Among 383 dialysis patients, 83.6% screened for moderate-to-extreme anxiety and 58% for PTSD; a separate study of 250 displaced adolescents found trauma exposure tracking closely with post-traumatic symptoms.
One study maps the five barriers that delayed life-saving crush-syndrome care; another finds the long-term health burden of the disaster fell hardest on young women.
A self-reported cross-sectional study of 599 residents found sharp deterioration across every measured dimension of oral health during the war — a neglected corner of the humanitarian-health picture.
Papers in WHO EMRO's journal document multidrug-resistant hospital infections in Saudi Arabia, unaffordable injectable antibiotics in Iran, and antibiotic use without prescription in displaced Syrians.
Peer-reviewed work in 2026 argues the effects reach past medicine shortages into financing, procurement, workforce and continuity of care — and frames the finding as association, not proof of cause.
Before October 2023, Palestinian health authorities had documented 50 people living with HIV in Gaza. A viewpoint argues the collapse of testing and treatment has since erased that count entirely.
A cross-sectional study of 96 war amputees, 53 caregivers and 95 community controls found sharply elevated disability and psychiatric symptoms, and argued for combined physical and mental-health rehabilitation.
A Bulletin of the WHO study recorded 168 maternal deaths between October 2023 and June 2024, alongside higher stillbirth, neonatal-death and preterm-birth rates than before the war.
Two peer-reviewed studies chart the toll: among 122 Khartoum dialysis patients followed for up to 18 months, 53% survived, and those who stayed in the capital fared worst.
A 23-year genetic-network analysis of 5,094 cases identified 107 molecular super-spreaders, mostly men aged 50-69, with 94.4% living within 2 km of major transport routes.
The barriers parents named most often were cost and the absence of any nearby service — not stigma, which the field has spent years treating as the main obstacle.